Molecular Pathology of Bladder Cancer

A special issue of Journal of Molecular Pathology (ISSN 2673-5261).

Deadline for manuscript submissions: closed (1 July 2021) | Viewed by 734

Special Issue Editor


E-Mail Website
Guest Editor
Guy's & St. Thomas' National Health Services Foundation Trust, Department of Cellular Pathology, St. Thomas' Hospital, London, UK
Interests: fine needle aspiration (FNA); endoscopic ultrasound; urological cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bladder cancer has trailed behind other malignancies in the routine application of molecular diagnostics. Whilst urine cytology has a high specificity for high grade lesions, the more common low grade lesions are reliant on cystoscopy for diagnosis and follow up. Any biomarkers that increase the yield of low (and high) grade lesions would increase in the interval between cystoscopies and focus clinical management of those patients most at risk from progressive bladder cancer. It is time to shortlist some of the most promising candidates in this long-running race for the best biomarker. We invite investigators to contribute original research articles as well as review articles and communications.

Dr. Ashish Chandra
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bladder
  • urothelial
  • carcinoma
  • biomarkers
  • urine
  • cytology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop